AZA-1

N/A

Report date: 2022/09/29 15:18:11
NME

Base Information

Drug NameAZA-1
Drug Alias NameAZA-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell division control protein 42 homolog inhibitorsRas-related C3 botulinum toxin substrate 1 inhibitors
TargetsCell division control protein 42 homologRas-related C3 botulinum toxin substrate 1
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedical University Of Vienna
China Registration ClassN/A

Develop Information

Active CompaniesMedical University Of Vienna
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A